APLM Company Profile and Key Details

Apollomics, Inc. (NASDAQ:APLM) closed at $23.20 USD, losing -$0.66 (-2.75%) from the previous close of $23.86. The stock is currently mid-range between its 52-week high and low $6.94 and $42.12. With a market capitalization of about $50.96 million, Apollomics, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.53). Key stats such as the average daily volume over the past year has been around 25.25 thousand shares, volume is running light vs its 52-week average. Headquartered in Foster City, CA, Apollomics, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Hung-Wen Chen, the company employs approximately 14 people and listed since November 26, 2021. Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia.

Apollomics, Inc. generated EPS of -$28.28 over the past year. Five-year average earnings growth is -28.54%. Apollomics, Inc. earnings surprise history is a mixed track record. The quarter that ended June 27, 2024, missed forecasts by 10.46%. The prior quarter beat by 25.19%. Over the last six quarters, Apple has recorded several small beats. These include 25.19% in March 28, 2024.

Short-term trend indicators are bearishly aligned (SMA20 3.25%, SMA50 5.24%, SMA200 68.92%). The stock’s 14-day RSI is 53.01 (neutral), while the ATR of 1.53 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -51.6% below its high and over 457.12% above its low. Average 10-day trading volume of 15.71 thousand shares is below the 3-month average of 24.79 thousand, indicating normal recent market interest.

Apollomics, Inc. has 2.91 million shares outstanding. The public float is 553.18 thousand shares, elevated short interest at 0.41% of float. This equals 7.41 thousand shares. The short ratio is 0.27 days. Institutional investors hold 0.11% of the float. Insiders own 47.1%. Chen Hung-Wen holds 315.00 thousand shares, Chen Yi-Kuei has 121.25 thousand shares and LIN PETER KUAN-HOW has 48.98 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Apollomics, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $6.16. This means the shares are trading above this model’s fair value.

Apollomics, Inc. trades at a P/E ratio of -2.93, slightly below the S&P 500 average, with a price-to-sales ratio of 5.74 and a price-to-book ratio of -2.93 indicating negative book value, which may reflect financial stress. The P/FCF stands at -4.7, also below market averages.

Our AI price prediction model suggests that Apollomics, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 20.47%, with price expected at $27.96 by September 25, 2026, within a range of $25.52 to $30.32 3-Month Outlook: Projected rise of 124.34%, reaching $52.07 by December 09, 2026, with a range of $51.29 to $52.88. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 10, 2027, within a range of $0.00 to $0.00.

Apollomics, Inc. (NASDAQ:APLM) shares are flat 7.68% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Apollomics, Inc. trading at a premium to the broader market with a P/E of -2.93. Our AI forecast model points to short-term strength (20.47% over two weeks), a medium-term rise (124.34% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.